Starlix and Coccydynia - a phase IV clinical study of FDA data
Summary:
Coccydynia is reported as a side effect among people who take Starlix (nateglinide), especially for people who are female, 40-49 old, also take Ibuprofen, and have Bone pain.
The phase IV clinical study analyzes which people have Coccydynia when taking Starlix. It is created by eHealthMe based on reports of 3,726 people who have side effects when taking Starlix from the FDA, and is updated regularly.
What is Starlix?
Starlix has active ingredients of nateglinide. It is often used in diabetes. eHealthMe is studying from 3,768 Starlix users. Check the latest studies of Starlix.
What is Coccydynia?
Coccydynia (pain in the coccyx or tailbone area) is found to be associated with 312 drugs and 325 conditions by eHealthMe. Check the latest studies of Coccydynia.
3,726 people reported to have side effects when taking Starlix.
Among them, 11 people (0.3%) have Coccydynia.

Among these 11 people:
What is the gender of people who have Coccydynia when taking Starlix? *
- female: 80 %
- male: 20 %
What is the age of people who have Coccydynia when taking Starlix? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 80 %
- 50-59: 0.0 %
- 60+: 20 %
What are other drugs people take besides Starlix? *
- Zyrtec: 11 people, 100.00%
- Zosyn: 11 people, 100.00%
- Alprazolam: 11 people, 100.00%
- Arimidex: 11 people, 100.00%
- Black Cohosh: 11 people, 100.00%
- Dilaudid: 11 people, 100.00%
- Diovan: 11 people, 100.00%
- Glucovance: 11 people, 100.00%
- Hydrochlorothiazide: 11 people, 100.00%
- Ibuprofen: 11 people, 100.00%
What are other side effects people have besides Coccydynia? *
- Wound Infection Staphylococcal: 11 people, 100.00%
- Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 11 people, 100.00%
- Facial Pain: 11 people, 100.00%
- Fall: 11 people, 100.00%
- Fever: 11 people, 100.00%
- Gastric Ulcer (stomach ulcer): 11 people, 100.00%
- Gingival Disorder (gum disease): 11 people, 100.00%
- Gingival Pain (gum pain): 11 people, 100.00%
- Head Injury: 11 people, 100.00%
- Hepatic Steatosis (fatty liver disease): 11 people, 100.00%
What are the existing conditions these people have? *
- Metastases To Bone (cancer spreads to bone): 11 people, 100.00%
- High Blood Pressure: 11 people, 100.00%
- Depression: 11 people, 100.00%
- Breast Cancer: 11 people, 100.00%
- Bone Pain: 11 people, 100.00%
- Breast Cancer Metastatic: 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Starlix and have Coccydynia?
- Check whether Coccydynia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Starlix:
- Starlix (3,768 reports)
Coccydynia treatments and more:
- Coccydynia (2,025 reports)
How severe was Coccydynia and when was it recovered:
Expand to all the drugs that have ingredients of nateglinide:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Starlix:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Coccydynia:
- Coccydynia (313 drugs)
Browse all the conditions that are associated with Coccydynia:
- Coccydynia (325 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on nateglinide (the active ingredients of Starlix) and Starlix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Verapamil Hydrochloride vs. Trandolapril, side effect and effectiveness comparison - 24 seconds ago
- Skin Infection and Gastroesophageal Reflux Disease - 32 seconds ago
- Drug interactions of Meloxicam and Agaricus - a minute ago
- Cardiac Failure Congestive and Shock Haemorrhagic - a minute ago
- Avandaryl vs. Humulin R, side effect and effectiveness comparison - a minute ago
- Drug interactions of Brintellix and Linzess - 2 minutes ago
- Relapsing-Remitting Multiple Sclerosis and Hallucination, Visual - 2 minutes ago
- Could Stivarga cause Dyschezia? - 2 minutes ago
- Could Relpax cause Skin Discoloration - Bluish? - 2 minutes ago
- Could Pantoprazole cause Heart Attack? - 3 minutes ago